Across years of archived threads on r/Peptides and related communities, the most consistently applied criteria for vendor evaluation fall into five categories: Third-party COA with named lab: Not an internal vendor document
Fatty acid conjugation as used in Semaglutide and Retatrutide promotes reversible albumin binding that shields the peptide from enzymatic degradation and slows renal filtration, extending the half-life from minutes to days
Choosing based on which one has more animal evidence is reasonable
Injection protocols and timing Separate injections: Semaglutide: Subcutaneous, abdomen or thigh Cagrilintide: Subcutaneous, different site Same day, different locations Both weekly Timing considerations: Most take both same day (simplicity) Can split: Semaglutide Monday, Cagrilintide Thursday No evidence one timing superior Choose based on preference Injection technique: Standard subcutaneous injection 29-31 gauge needles Rotate injection sites No special requirements See our peptide injections guide , how to calculate peptide dosages , and how to reconstitute peptides if using research peptides
However, a common question that arises is: Do peptides appear on drug tests
.webp)
